BEIJING, May 20, 2016 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the preliminary opening of its wholly-owned Datong Meizhongjiahe Cancer Hospital ( "Datong Hospital").
The company received relevant government approvals to establish Datong Hospital in October 2014. Located in Datong, Shanxi Province, the 100-bed hospital was registered as Level-II specialty cancer hospital with mandatory departments including radiation, imaging, test laboratory, inpatient, and nursing. This hospital will apply to join the local social insurance coverage. The hospital is equipped with the advanced radiotherapy and diagnostic imaging equipment, including linear accelerator and MRI.
Dr. Jianyu Yang, Chairman and CEO of Concord Medical, commented, "We are very pleased to celebrate the transformative milestone in the history of Concord Medical. This first wholly-owned domestic cancer hospital in China is an important step of our broad strategy to build a nationwide chain of free-standing cancer treatment and diagnosis centers under the brand "Meizhongjiahe" in the future. Currently we are expanding in the domestic market to establish specialty cancer hospitals in cities such as Wuxi, Hangzhou, Taizhou, and Nanchang. Through our Meizhongjiahe network, we are committed to provide advanced, best-practice diagnostic and treatments for patients in Tier II and Tier III cities, where there is strong patient demand but limited oncology medical services. Being an essential part of our expansion plan, Meizhongjiahe network will be complementary to our high-end hospitals in Tier I cities.
Currently, the healthcare reform has touched upon many historically challenging issues, such as multi-location practice for doctors and equipment licensing to private hospitals. We will capitalize on this growing opportunity and rely on our excellent doctor resources as well as strong medical network to contribute to the improvement of overall level of cancer treatment and diagnosis in China, generating long-term and stable returns for our shareholders."
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of December 31, 2015, the Company operated a network of 127 centers with 76 hospital partners that spanned 53 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. As part of its high-end cancer hospital development strategy and oversea business extension, the Company acquired Concord Cancer Hospital, a private hospital in Singapore in April, 2015. For more information, please see http://ir.concordmedical.com.
For more information, please contact:
Concord Medical Services
Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com
Ms. Fang Liu (Chinese and English)
+86 10 5903 6688 (ext. 639)
fang.liu@concordmedical.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/concord-medical-announces-preliminary-opening-of-datong-meizhongjiahe-cancer-hospital-300272291.html
SOURCE Concord Medical Services Holdings Limited
